Ipsen at a glance


Improving the lives of patients is what drives us. The search for innovative solutions to disabling conditions is at the heart of everything we do. Increased life expectancy is making the pursuit of our inspiring vocation more vital than ever: finding effective therapeutic solutions to cure disease, relieve suffering and bring value to the community.


We aim to be among the top 10 pharmaceutical companies in the world, in terms of growth and profitability. We want to be respected above all for our strategic model, our success, and the commitment of our teams towards patients.

3 targeted specialty care areas

Ipsen focuses its resources and investments on three targeted specialty care areas, organized in Franchises. In these areas, Ipsen operates throughout the entire value chain, from research through to marketing.

Primary care

Ipsen has also a significant presence in primary care and offers treatment mainly in

2013 Key figures

  • Sales of more than €1.2 billion
  • Drugs marketed in 115 countries
  • 3/4 of sales generated by specialty care drugs
  • R&D expenditure close to €187 million representing about 15% of sales
  • ¾ of sales generated outside France
  • More than 4,500 employees worldwide, of which 900 contribute to R&D